Tandem Diabetes Care (TNDM) Change in Inventory (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Change in Inventory came in at -$1.9 million in Q1 2026, up 79.93% YoY from -$1.1 million in Q1 2025, and up 74.52% on a QoQ basis from -$7.6 million in Q4 2025.
Tandem Diabetes Care (TNDM) Change in Inventory (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Change in Inventory data on file, last reported at -$1.9 million in Q1 2026.
- Quarterly Change in Inventory rose 79.93% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.1 million (down 39.89% YoY) and the FY2025 annual result came in at -$24.8 million, down 327.13% from the prior year.
- Change in Inventory rose to -$1.9 million in Q1 2026, from -$7.6 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $19.9 million in Q1 2023 to a low of -$10.4 million in Q3 2024.
- A 5-year average of $3.3 million and a median of -$595000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory soared 7149.58% — and 2025, when it slumped 1171.26%.
- Tracing TNDM's Change in Inventory over 5 years: stood at $5.4 million in 2022, then surged by 147.48% to $13.3 million in 2023, then tumbled by 104.46% to -$595000.0 in 2024, then tumbled by 1171.26% to -$7.6 million in 2025, then soared by 74.52% to -$1.9 million in 2026.
- The last three Change in Inventory figures came in at -$1.9 million (Q1 2026), -$7.6 million (Q4 2025), and -$5.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 301.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 113.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 133.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 23.50 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 36.40 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 139.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -131.35 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 73.30 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | 10.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.49 Mn |
| Jun 30, 2026 | 10.49 Mn |
| Mar 31, 2026 | -1.93 Mn |
| Mar 31, 2026 | -1.93 Mn |
| Dec 31, 2025 | -7.56 Mn |
| Dec 31, 2025 | -7.56 Mn |
| Sep 30, 2025 | -5.19 Mn |
| Sep 30, 2025 | -5.19 Mn |
| Jun 30, 2025 | -2.46 Mn |
| Jun 30, 2025 | -2.46 Mn |
| Mar 31, 2025 | -9.60 Mn |
| Mar 31, 2025 | -9.60 Mn |
| Dec 31, 2024 | -595,000.00 |
| Dec 31, 2024 | -595,000.00 |
| Sep 30, 2024 | -10.37 Mn |
| Sep 30, 2024 | -10.37 Mn |
| Jun 30, 2024 | 8.31 Mn |
| Jun 30, 2024 | 8.31 Mn |
| Mar 31, 2024 | -3.16 Mn |
| Mar 31, 2024 | -3.16 Mn |